Apobiologix wins patent case against Amgen

13-09-2016

Apobiologix wins patent case against Amgen

Piotr Adamowicz / Shutterstock.com

Biosimilars company Apobiologix has won a patent infringement litigation against Amgen centring on the drugs Grastofil (filgrastim) and Lapelga (pegfilgrastim).


Federal Circuit, Apobiologix, patent, Amgen, Grastofil, Lepelga, US Supreme Court, BPCIA, biosimilars

LSIPR